Ledger.Open graph →
SEC Form D · filed February 21, 2023

Tellus Therapeutics, Inc

Offering
$35.0M
Sold
$16.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Eric J. Benner · Durham, NCExec · DirectorFred J. Callori · Hillsborough, NCDirectorChris J. Garabedian · Hillsborough, NCDirectorJason E. Kralic · Hillsborough, NCExec · DirectorChris J. Garabedian · Hillsborough, NCDirectorJason E. Kralic · Hillsborough, NCExec · DirectorEric J. Benner · Durham, NCExec · DirectorFred J. Callori · Hillsborough, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗